Open AccessCell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams-075
Author(s) -
Gaëlle Labouré,
Marie-Cecile Parrens,
Anjarasoa Tsaranazy,
M Bordier,
Steven Le Gouill,
Vincent Delwail,
Rémy Gressin,
Jérôme Cornillon,
Gandhi Damaj,
Charles Foussard,
Hervé Maisonneuve,
Éric Deconinck,
Guillaume Cartron,
F. Dreyfus,
Emmanuel Gyan,
Laurent Sutton,
Nadine Morineau,
Magda Alexis,
Anne Banos,
Diane Damotte,
Anne Moreau,
Françoise KraeberBodéré,
Karin Tarte,
Thierry Fest,
Thierry Lamy,
Noël Milpied
Publication year - 2013
Publication title -
hal (le centre pour la communication scientifique directe)
Language(s) - English
Resource type - Conference proceedings
Subject(s) - front line , regimen , medicine , outcome (game theory) , oncology , political science , law , mathematics , mathematical economics